Ostadal相关文献与解析，生知库 | 链接生命科学的每一步

Knitlova Jarmila, Eckhardt Adam, Hadraba Daniel, Vondrasek David, Stachon Roman, Filova Elena, Jencova Vera, Havlickova Kristyna, Kobets Tatyana, Ostadal Martin, Bacakova Lucie

发表日期：2026

文献求助收藏

Improvement of Cardiac Function by Polyclonal Antibodies Against Ca(2+)/Mg(2+) ecto-ATPase in Hearts Subjected to Ischemia-Reperfusion

多克隆抗体通过抑制Ca(2+)/Mg(2+)胞外ATPase改善缺血再灌注损伤心脏的心脏功能

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms27042002

Dhalla, Naranjan S; Elimban, Vijayan; Ostadal, Petr

发表日期：2026

文献求助收藏

Cardiac index, SvO(2) or pCO(2) gap may determine benefit from ECMO in cardiogenic shock: post-hoc analysis of the multicenter, randomized ECMO-CS trial

心脏指数、SvO₂ 或 pCO₂ 差值可能决定 ECMO 在心源性休克中的获益：多中心随机 ECMO-CS 试验的事后分析

期刊:Critical Care

影响因子:9.3

doi:10.1186/s13054-025-05513-5

Ostadal, Petr; Vondrakova, Dagmar; Rokyta, Richard; Karasek, Jiri; Kruger, Andreas; Janotka, Marek; Naar, Jan; Smalcova, Jana; Hubatova, Marketa; Hromadka, Milan; Volovar, Stefan; Seyfrydova, Miroslava; Linhart, Ales; Belohlavek, Jan

Adhesion/ECM

发表日期：2025

文献求助收藏

Involvement of Oxidative Stress and Antioxidants in Modification of Cardiac Dysfunction Due to Ischemia-Reperfusion Injury

氧化应激和抗氧化剂在缺血再灌注损伤引起的心脏功能障碍的改善中的作用

期刊:Antioxidants

影响因子:6.6

doi:10.3390/antiox14030340

Dhalla, Naranjan S; Ostadal, Petr; Tappia, Paramjit S

Epitranscriptomic signatures in blood: emerging biomarkers for diagnosis of diabetes and its complications

血液中的表观转录组特征：糖尿病及其并发症诊断的新兴生物标志物

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2025.1656769

Hlavackova, Marketa; Benak, Daniel; Holzerova, Kristyna; Alanova, Petra; Hrdlicka, Jaroslav; Chalupova, Miloslava; Opletalova, Barbora; Ostadal, Bohuslav; Kolar, Frantisek

Involvement of Oxidative Stress in Mitochondrial Abnormalities During the Development of Heart Disease

氧化应激参与心脏病发展过程中线粒体异常的发生

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines13061338

Dhalla, Naranjan S; Ostadal, Petr; Tappia, Paramjit S

2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)

2024 年关于已确诊动脉粥样硬化性心血管疾病和急性冠状动脉综合征后降脂治疗最佳应用的建议：国际脂质专家组 (ILEP) 的立场文件

期刊:Drugs

影响因子:14.4

doi:10.1007/s40265-024-02105-5

Banach, Maciej; Reiner, Željko; Surma, Stanisław; Bajraktari, Gani; Bielecka-Dabrowa, Agata; Bunc, Matjaz; Bytyçi, Ibadete; Ceska, Richard; Cicero, Arrigo F G; Dudek, Dariusz; Dyrbuś, Krzysztof; Fedacko, Jan; Fras, Zlatko; Gaita, Dan; Gavish, Dov; Gierlotka, Marek; Gil, Robert; Gouni-Berthold, Ioanna; Jankowski, Piotr; Járai, Zoltán; Jóźwiak, Jacek; Katsiki, Niki; Latkovskis, Gustavs; Magda, Stefania Lucia; Margetic, Eduard; Margoczy, Roman; Mitchenko, Olena; Durak-Nalbantic, Azra; Ostadal, Petr; Paragh, Gyorgy; Petrulioniene, Zaneta; Paneni, Francesco; Pećin, Ivan; Pella, Daniel; Postadzhiyan, Arman; Stoian, Anca Pantea; Trbusic, Matias; Udroiu, Cristian Alexandru; Viigimaa, Margus; Vinereanu, Dragos; Vlachopoulos, Charalambos; Vrablik, Michal; Vulic, Dusko; Penson, Peter E

Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial

坎格瑞洛与压碎的替格瑞洛治疗急性心肌梗死合并心源性休克患者的疗效比较：随机、双盲 DAPT-SHOCK-AMI 试验的原理和设计

期刊:EuroIntervention

影响因子:9.5

doi:10.4244/EIJ-D-24-00203

Motovska, Zuzana; Hlinomaz, Ota; Mrozek, Jan; Kala, Petr; Geisler, Tobias; Hromadka, Milan; Akin, Ibrahim; Precek, Jan; Kettner, Jiri; Cervinka, Pavel; Montalescot, Gilles; Jarkovsky, Jiri; Belohlavek, Jan; Bis, Josef; Matejka, Jan; Vodzinska, Alexandra; Muzafarova, Tamilla; Tomasov, Pavol; Schee, Alexander; Bartus, Stanislav; Andrasova, Andrea; Olivier, Christoph B; Kovarik, Ales; Ostadal, Petr; Demlova, Regina; Souckova, Lenka; Vulev, Ivan; Coufal, Zdeněk; Kochman, Janusz; Marinov, Iuri; Kubica, Jacek; Ducrocq, Gregory; Karpisek, Michal; Klimsa, Zdenek; Hudec, Martin; Widimsky, Petr; Bhatt, Deepak L; Group, Dapt-Shockami Study

Diabetes mellitus in stable chronic heart failure and the combination with humoral activation, their association, and prediction of 2-year adverse outcomes. Data from the FAR NHL registry

糖尿病合并稳定型慢性心力衰竭及其与体液激活的关联性及其对2年不良预后的预测。数据来自FAR NHL注册研究。

期刊:Journal of Diabetes

影响因子:3.7

doi:10.1111/1753-0407.13605

Labr, Karel; Spinar, Jindrich; Parenica, Jiri; Spinarova, Lenka; Krejci, Jan; Malek, Filip; Ostadal, Petr; Ludka, Ondrej; Jarkovsky, Jiri; Benesova, Klara; Labrova, Ruzena; Spinarova, Monika

What is cardiogenic shock? New clinical criteria urgently needed

什么是心源性休克？迫切需要新的临床标准。

期刊:Current Opinion in Critical Care

影响因子:3.4

doi:10.1097/MCC.0000000000001172

Ostadal, Petr; Belohlavek, Jan

发表日期：2024

文献求助收藏

Development of a 3D In Vitro Model of Dupuytren's Disease as a Platform for Drug Screening.

开发杜普伊特伦氏挛缩症的三维体外模型作为药物筛选平台。

Improvement of Cardiac Function by Polyclonal Antibodies Against Ca(2+)/Mg(2+) ecto-ATPase in Hearts Subjected to Ischemia-Reperfusion

多克隆抗体通过抑制Ca(2+)/Mg(2+)胞外ATPase改善缺血再灌注损伤心脏的心脏功能

Cardiac index, SvO(2) or pCO(2) gap may determine benefit from ECMO in cardiogenic shock: post-hoc analysis of the multicenter, randomized ECMO-CS trial

心脏指数、SvO₂ 或 pCO₂ 差值可能决定 ECMO 在心源性休克中的获益：多中心随机 ECMO-CS 试验的事后分析

Involvement of Oxidative Stress and Antioxidants in Modification of Cardiac Dysfunction Due to Ischemia-Reperfusion Injury

氧化应激和抗氧化剂在缺血再灌注损伤引起的心脏功能障碍的改善中的作用

Epitranscriptomic signatures in blood: emerging biomarkers for diagnosis of diabetes and its complications

血液中的表观转录组特征：糖尿病及其并发症诊断的新兴生物标志物

Involvement of Oxidative Stress in Mitochondrial Abnormalities During the Development of Heart Disease

氧化应激参与心脏病发展过程中线粒体异常的发生

2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)

2024 年关于已确诊动脉粥样硬化性心血管疾病和急性冠状动脉综合征后降脂治疗最佳应用的建议：国际脂质专家组 (ILEP) 的立场文件

Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trial

坎格瑞洛与压碎的替格瑞洛治疗急性心肌梗死合并心源性休克患者的疗效比较：随机、双盲 DAPT-SHOCK-AMI 试验的原理和设计

Diabetes mellitus in stable chronic heart failure and the combination with humoral activation, their association, and prediction of 2-year adverse outcomes. Data from the FAR NHL registry

糖尿病合并稳定型慢性心力衰竭及其与体液激活的关联性及其对2年不良预后的预测。数据来自FAR NHL注册研究。

What is cardiogenic shock? New clinical criteria urgently needed

什么是心源性休克？迫切需要新的临床标准。